Global Non-oncology Biopharmaceuticals Market Size, Status and Forecast 2019-2025

SKU ID : QYR- 13468087

Publishing Date : 16-May-2019

No. of pages : 100

PRICE
3900
7800


  • Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial. This report studies Non-oncology biopharmaceutical which are the drugs that are used in the treatment of various diseases rather than cancer.
    In 2018, the global Non-oncology Biopharmaceuticals market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

    This report focuses on the global Non-oncology Biopharmaceuticals status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-oncology Biopharmaceuticals development in United States, Europe and China.

    The key players covered in this study
    Roche
    Sanofi
    Johnson & Johnson
    Pfizer
    Novo Nordisk
    Novartis
    Merck
    Teva
    Eli Lilly
    Bristol-Myers Squibb
    GlaxoSmithKline
    UCB Pharma
    Amgen
    AbbVie
    Takeda
    AstraZeneca
    Mylan
    LEO Pharma
    Boehringer Ingelheim
    Alexion Pharmaceuticals
    Elusys Therapeutics
    Swedish Orphan Biovitrum
    Biogen

    Market segment by Type, the product can be split into
    Biologics
    Biosimilars

    Market segment by Application, split into
    Immunology
    Endocrinology
    Others

    Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Non-oncology Biopharmaceuticals status, future forecast, growth opportunity, key market and key players.
    To present the Non-oncology Biopharmaceuticals development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

    In this study, the years considered to estimate the market size of Non-oncology Biopharmaceuticals are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.